RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)

Dades bibliogràfiques
Autors principals:	Apperley, J, Hows, J, Hale, G, Waldmann, H, Gordonsmith, E, Goldman, J
Format:	Journal article
Publicat:	1985

Ítems similars

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
per: Mackinnon, S, et al.
Publicat: (1988)

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
per: Mackinnon, S, et al.
Publicat: (1988)

Bone marrow transplantation for patients with chronic myeloid leukemia.
per: Goldman, J, et al.
Publicat: (1986)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
per: Mackinnon, S, et al.
Publicat: (1988)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
per: Apperley, J, et al.
Publicat: (1986)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1988)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
per: Waldmann, H, et al.
Publicat: (1985)

HISTOCOMPATIBLE UNRELATED VOLUNTEER DONORS FOR BMT IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA
per: Mackinnon, S, et al.
Publicat: (1988)

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
per: Apperley, J, et al.
Publicat: (1986)

Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.
per: Mackinnon, S, et al.
Publicat: (1990)

Availability of Campath-1 antibodies for bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1994)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
per: Hale, G, et al.
Publicat: (1998)

Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.
per: Cullis, J, et al.
Publicat: (1993)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
per: Novitzky, N, et al.
Publicat: (1999)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
per: Waldmann, H, et al.
Publicat: (1985)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
per: Waldmann, H, et al.
Publicat: (1987)

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
per: Spencer, A, et al.
Publicat: (1995)

BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS FOR CML IN CHRONIC PHASE
per: Cullis, J, et al.
Publicat: (1991)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
per: Naparstek, E, et al.
Publicat: (1993)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
per: Fibbe, W, et al.
Publicat: (1993)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
per: Novitzky, N, et al.
Publicat: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
per: Novitzky, N, et al.
Publicat: (1997)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
per: Slavin, S, et al.
Publicat: (1985)

EVALUATION OF OUTCOME AND CHIMERIC STATUS FOLLOWING HLA IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA USING IN-VIVO CAMPATH-1G
per: Hamblin, M, et al.
Publicat: (1995)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
per: Davison, G, et al.
Publicat: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
per: Davison, G, et al.
Publicat: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
per: Davison, G, et al.
Publicat: (1998)

MATCHED UNRELATED DONOR BMT FOR CML - COMPARISON OF EXVIVO AND INVIVO T-CELL DEPLETION
per: Cullis, J, et al.
Publicat: (1992)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
per: Heit, W, et al.
Publicat: (1986)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1985)

Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.
per: Cornish, J, et al.
Publicat: (1996)

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
per: Willemze, R, et al.
Publicat: (1992)

Amplification of mitochondrial DNA in CGL in transformation.
per: Fidler, C, et al.
Publicat: (1996)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
per: Hale, G, et al.
Publicat: (1994)

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.
per: Singhal, S, et al.
Publicat: (1996)

CAMPATH-1 antibodies in stem-cell transplantation.
per: Hale, G, et al.
Publicat: (2001)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
per: Novitzky, N, et al.
Publicat: (2004)

CHARACTERIZATION OF BLAST CELLS IN CHRONIC GRANULOCYTIC-LEUKEMIA IN TRANSFORMATION, ACUTE MYELOFIBROSIS AND UNDIFFERENTIATED LEUKEMIA .2. STUDIES WITH MONOCLONAL-ANTIBODIES AND TERMINAL TRANSFERASE
per: Miguel, J, et al.
Publicat: (1985)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
per: Naparstek, E, et al.
Publicat: (1999)